Karen Sims

This profile gathers the share dealings of Karen Sims in Arbutus Biopharma Corp. In total, 3 filings cover trades dated from 1 February 2024 to 14 February 2025.

Every open-market trade on record is a sale: 1 sale worth €62k. The rest of the record consists of 2 share grants. Since January 2025: no purchases and 1 sale on the market.

The record was last updated on 19 February 2025 with a share grant in Arbutus Biopharma Corp. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.